HomeGLAND • NSE
add
Gland Pharma Ltd
Previous close
₹1,895.70
Day range
₹1,843.10 - ₹1,904.90
Year range
₹1,277.80 - ₹2,131.00
Market cap
311.50B INR
Avg Volume
245.36K
P/E ratio
36.56
Dividend yield
0.96%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 16.95B | 22.49% |
Operating expense | 7.37B | 22.29% |
Net income | 2.61B | 27.74% |
Net profit margin | 15.42 | 4.26% |
Earnings per share | 16.98 | 36.68% |
EBITDA | 4.17B | 20.90% |
Effective tax rate | 27.79% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.02B | 9.26% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 95.63B | — |
Shares outstanding | 164.76M | — |
Price to book | 3.27 | — |
Return on assets | — | — |
Return on capital | 8.29% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 2.61B | 27.74% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1978
Website
Employees
4,351
